Myc stimulates B lymphocyte differentiation and amplifies calcium signaling by Habib, Tania et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: ARTICLE
© The Rockefeller University Press    $30.00
The Journal of Cell Biology, Vol. 179, No. 4, November 19, 2007 717–731
http://www.jcb.org/cgi/doi/10.1083/jcb.200704173
JCB 717
Introduction
Members of the Myc family of nuclear protooncogenes are 
known to stimulate cell division and transformation. However, 
the roles of Myc in cell differentiation have been diffi  cult to as-
sess, in part because of the early embryonic lethality of N-myc– 
(Charron et al., 1992) and c-myc (Davis et al., 1993)–null mice 
and the diffi  culties in experimentally distinguishing proliferation 
from differentiation using in vitro approaches. In this study, we 
used B cell–specifi  c deletion or overexpression of c- and/or 
N-myc to explore the roles of Myc in B lymphocyte development 
and lymphoma formation. B cell development in the bone marrow 
(BM) and fetal liver are marked by a series of cell fate decisions, 
which are controlled by checkpoints that ensure that all mature 
B lymphocytes are capable of producing functional antibodies 
(for review see Hendriks and Middendorp, 2004). Pluripotent 
hematopoietic progenitors initially become committed to the 
B lineage in response to growth factors and stromal cell inter-
actions. The least mature committed B cell progenitors, called 
pro–B cells, have their Ig heavy chain (HC) and light chain (LC) 
genes in germline (GL) confi  guration. The Ig HC genes rearrange 
before the Ig LCs, and with successful in-frame DH-JH and then 
VH-DH-JH juxtaposition, the Ig HCμ appears at the cell surface 
along with the signal-transducing proteins Igα and Igβ and the 
surrogate LC λ5 and Vpre-B1 and 2 as a complex called the pre–
B cell receptor (BCR; termed large pre–B cells). The pre-BCR 
then signals large pre–B cells to proliferate, mature to the small 
pre–B cell stage, extinguish rearrangement of the other allele 
of the Ig HC (a process called allelic exclusion), and initiate 
Ig LC transcription and rearrangement (Vκ and Vλ). Successful 
in-frame Ig VL-JL rearrangement allows the Ig HC and LC pro-
teins to pair and form IgM molecules on the surface of immature 
B cells, at which point they migrate from the BM to the peri-
phery, where development continues.
Formation of the pre-BCR represents a critical checkpoint 
for ensuring that maturing B cells have in-frame VH-DH-JH gene 
rearrangements. Signaling is induced by pre-BCR aggregation 
in lipid rafts, resulting in activation of the Src family protein 
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  D
eregulated expression of the Myc family of tran-
scription factors (c-, N-, and L-myc) contributes to 
the development of many cancers by a mechanism 
believed to involve the stimulation of cell proliferation and 
inhibition of differentiation. However, using B cell–speciﬁ  c 
c-/N-myc double-knockout mice and Eμ-myc trans-
genic mice bred onto genetic backgrounds (recombinase-
  activating gene 2
−/− and Btk
−/− Tec
−/−) whereby B cell 
development is arrested, we show that Myc is necessary to 
stimulate both proliferation and differentiation in primary 
B cells. Moreover, Myc expression results in sustained 
increases in intracellular Ca
2+ ([Ca
2+]i), which is required 
for Myc to stimulate B cell proliferation and differentiation. 
The increase in [Ca
2+]i correlates with constitutive nuclear 
factor of activated T cells (NFAT) nuclear translocation, 
reduced Ca
2+ efﬂ  ux, and decreased expression of the 
plasma membrane Ca
2+–adenosine triphosphatase (PMCA) 
efﬂ  ux pump. Our ﬁ  ndings demonstrate a revised model 
whereby Myc promotes both proliferation and differentia-
tion, in part by a remarkable mechanism whereby Myc 
ampliﬁ  es Ca
2+ signals, thereby enabling the concurrent 
expression of Myc- and Ca
2+-regulated target genes.
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tyrosine kinases (PTKs) Blk, Lyn, and Fyn, which then phos-
phorylate tyrosine residues within Igα and Igβ. This results in 
recruitment and activation of the Syk PTK (and to a lesser ex-
tent ZAP70) and the adaptor SLP-65 (also known as BASH or 
BLNK). Phosphorylation of SLP-65 by Syk further activates 
multiple signaling pathways, including the Ras–Raf and phos-
phatidylinositol 3-kinase (PI3K) pathways, as well as the Tec 
family PTKs Btk and Tec, which, together with Syk, activate 
PLCγ, resulting in Ca
2+ mobilization (see Fig. 8; for review 
see Hendriks and Middendorp, 2004). Altogether, these events 
result in expression and/or activation of a set of transcrip-
tion factors including extracellular regulated kinase, nuclear 
factor of activated T cells (NFAT), nuclear factor κB (NF-κB), 
and Myc.
Targeted deletion studies in mice have revealed essential 
roles for the majority of the described surface and cytoplas-
mic molecules in the development of pre–B cells (for review 
see Hendriks and Middendorp, 2004). However, the roles 
of nuclear factors such as Myc in B cell development remain 
unclear, in part because of genetic redundancy by related tran-
scription family members or lethality after tissue-wide dele-
tion. The Myc family of basic helix-loop-helix transcription 
factors bind DNA sequences called E boxes (CACGTG) as a 
heterodimer with the related basic helix-loop-helix factor Max 
(for review see Eisenman, 2001). This results in initiation of 
transcription, although transcriptional repression by Myc has 
been noted, probably through inhibition of the Miz-1 transcrip-
tion factor (Li et al., 1994; Staller et al., 2001). Of the three 
mammalian myc family members, only c- and N-myc are ex-
pressed in B lymphocytes. c-myc is initially expressed during 
the pro–B cell stage in response to cytokines, including IL-7 
(Morrow et al., 1992; Dillon and Schlissel, 2002). After pre-
BCR expression in large pre–B cells, both c- and N-myc are 
  expressed during the maturation and expansion to small pre–B 
cells (Zimmerman and Alt, 1990). Thereafter, only c-myc is ex-
pressed in immature and mature B cells after B cell activation. 
In this study, we took a unique genetic approach in mice to 
show that Myc stimulates B cell differentiation and expansion 
downstream of the pre-BCR and Tec PTKs. Moreover, we un-
cover a novel feature of Myc in amplifying [Ca
2+]i as a mecha-
nism to concurrently stimulate the expression of both Myc and 
Ca
2+-regulated genes, which are essential for both cell division 
and differentiation.
Results
Mice deﬁ  cient in Myc have impaired pre–B 
cell development
To examine the roles of Myc in early B cell development and 
to overcome potential functional redundancy between c- and 
N-myc, we generated mice defi  cient in both N- and c-myc 
genes selectively in B cells using the Cre-loxP system (Sauer, 
2002). c-myc
fl / fl  mice (de Alboran et al., 2001) were bred to 
N-myc
fl/fl mice (Knoepfl  er et al., 2002), which also carried 
the CD19cre transgene (Tg), to generate N-myc
fl/fl c-myc
fl/fl 
CD19cre
+ mice. The CD19 promoter drives expression of the Cre 
recombinase only in B lineage cells throughout their development 
(Rickert et al., 1997). Semi-quantitative PCR (qPCR) analysis 
of sorted B220
+CD43
+ and B220
+CD43
− B cell progenitors in 
the BM revealed  75/90% deletion of c-myc and  70/95% dele-
tion of N-myc genes, res  pectively, in the presence of CD19cre 
(Fig. S1 A, available at http://www.jcb.org/cgi/content/full/
jcb.200704173/DC1).
Total BM cells were isolated from mice defi  cient in 
c- and/or N-myc selectively in B cells, and B cell development 
was analyzed using fl  ow cytometry (see Fig. 3 A; Hardy and 
Hayakawa, 2001). Decreasing c-myc expression alone (c-myc
fl  /fl   
CD19cre
+) impairs the generation of B220
+CD43
− pre–B cells, 
whereas decreasing N-myc expression alone (N-myc
fl  /fl   CD19cre
+) 
does not consistently have any effect (unpublished data). How-
ever, depletion of total myc expression in N-myc
fl/fl c-myc
fl/fl 
CD19cre
+ mice results in maximal decreases in the percentage 
(Fig. 1 A) and number (Fig. 1 B) of B220
+CD43
−, B220
+IA
b+ 
pre–B cells, immature B cells (B220
loIgM
+), and mature B cells 
(B220
hiIgM
+) relative to CD19cre
− mice. These results suggest 
that Myc is required for pro–B to pre–B cell maturation.
In mice, pre–B cells proliferate in response to cytokines 
such as IL-7 produced by BM stromal cells (Fleming and 
Paige, 2002). Because IL-7 signaling is known to stimulate the 
expression of c-myc, we examined the ability of B cell pro-
genitors to divide in response to IL-7. Total BM cells from 
N-myc
fl / fl  c-myc
fl / fl  CD19cre
+ or CD19cre
− mice were labeled 
with 5-carboxyfl  uorescein diacetate succinimidyl ester (CFSE) 
and cultured in the presence or absence of IL-7 for 36 h, and 
the cell division profi  le of B cell progenitors was examined. 
As shown in Fig. 1 C, the majority of B cell progenitors from 
either N-myc
fl / fl  c-myc
fl / fl  CD19cre
− or CD19cre
+ mice do not 
divide in the absence of IL-7. However, in response to IL-7, 
pre–B cells from CD19cre
− mice undergo an average of four 
divisions, whereas cells from CD19cre
+ mice either do not di-
vide at all or undergo several divisions, likely as a result of the 
loss of cells that contain the deleted c-myc alleles (Fig. S1 B; 
de Alboran et al., 2001).
To determine whether the reduction in myc levels affects 
the development of peripheral B cells, we purifi  ed splenocytes 
from N-myc
fl  /fl   c-myc
fl  /fl   CD19cre
+ and CD19cre
− mice and charac-
terized B cell subsets by fl  ow cytometry. Splenic B cells are 
subdivided into additional stages of maturation and function, 
including transitional 1 and 2 (T1 and T2), follicular mature, 
and marginal zone (MZ; Hardy and Hayakawa, 2001). As shown 
in Fig. 2 A, CD19cre
+ mice exhibit a signifi  cant reduction in the 
number of all B cell subsets. This correlates with reduced serum 
IgM, IgG2a, and IgG1 in CD19cre
+ compared with CD19cre
− 
mice after immunization with keyhole limpet hemocyanin (KLH; 
Fig. 2 C). These results suggest that Myc regulates fi  nal B cell 
numbers in part by regulating pre–B cell development and, 
  potentially, peripheral B cell differentiation.
Peripheral B cells can be further classifi  ed as B2 conven-
tional B cells, which reside in lymphoid tissues such as the 
spleen, and as B1 B cells, which represent the majority of B cells 
found in peritoneal and pleural cavities and are IgM
hi, CD5
+/−, 
and CD23
−. As shown in Fig. 2 B, deletion of c- and N-myc 
  together results in a decrease in both CD5
loIgM
hi peritoneal B1 
B cells and CD5
−IgM
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Myc is essential for the development of both B2 and B1 B cells 
and for establishing fi  nal B cell numbers.
E𝗍-myc Tg stimulates the maturation and 
expansion of RAG2-null pro–B cells
It is unclear from the gene-targeting strategy whether the effects 
of Myc are exclusively in modulating the expansion of a popu-
lation of cells that have already differentiated to the pre–B cell 
stage or whether Myc may also stimulate the differentiation of 
pre-BCR
+ cells. To address this question, we took a classical 
genetic approach to determine whether Myc could rescue B cell 
differentiation in the absence of upstream signaling molecules 
known to be required for both myc expression and pre–B cell 
differentiation. In pre–B cells, myc genes are expressed, in part, 
by a pathway involving pre-BCR formation; the activation of 
Tec kinases, PLCγ, and PKC; and NF-κB translocation to the 
myc promoter (see Fig. 8; Grumont et al., 2002). First, we deter-
mined whether Myc could rescue B cell differentiation in the 
absence of pre-BCR formation by breeding Eμ-myc transgenic 
mice (Harris et al., 1988), which express c-myc exclusively in 
B lineage cells throughout development, to mice defi  cient in 
recombinase-activating gene 2 (RAG2; Shinkai et al., 1992), a 
gene required for the initiation of V(D)J recombination. RAG2
−/− 
mice lack pre-BCR expression, resulting in a complete block 
in B cell development at the B220
+CD43
+CD25
− pro–B cell 
stage (Fig. 3 A, Hardy fraction C). We fi  nd that c-myc Tg is 
 suffi  cient to stimulate the differentiation of RAG2-defi  cient 
pro–B cells based on the acquisition of pre–B cell character-
istics, including the down-regulation of CD43 and the up-
  regulation of CD25, IA
b, CD22, and heat-stable antigen (HSA; 
Fig. 3, A–C). This translates to a rescue in the relative number 
of pre–B-like cells to a level equivalent to that of wild-type 
(Wt) mice based on an increase in the number and ratio of 
B220
+CD43
− cells to B220
+CD43
+ cells in BM from Eμ-myc/
RAG2
−/− as compared with RAG2
−/− mice (unpublished data). 
c-Myc also stimulates GL transcription of the Igκ LC in puri-
fi  ed B cell progenitors from Eμ-myc/RAG2
−/− as compared 
with RAG2
−/− mice (Fig. 3, A and D). Myc does not appear 
to induce allelic exclusion of the Ig HC (Fig. S2 C, available 
at http://www.jcb.org/cgi/content/full/jcb.200704173/DC1), sug-
gesting that Myc Tg is not suffi  cient to mediate all of the signals 
from the pre-BCR.
Figure 1.  Deletion of c-and N-myc in B lineage cells results in impaired pre–B cell development. (A) Deletion of c-and N-myc in B lineage cells leads to a 
reduction in the pre–B, immature B, and mature B cell compartments in the BM. Flow cytometric analysis of BM cells stained with αB220, αCD43, αIgM, 
and αIA
b. Numbers indicate the percentage of cells in each region. (B) Total BM cells were stained with αB220, αCD43, and αIgM and analyzed by ﬂ  ow 
cytometry. Relative numbers of each population were determined as described in Materials and methods. Bars represent the mean ± SEM (error bars) ob-
tained from three CD19cre
− and four CD19cre
+ animals. *, P < 0.005. (C) Deletion of c-and N-myc results in impaired pre–B cell proliferation. BM cells 
from mice of the indicated genotypes were labeled with CFSE and cultured in the absence (left) or presence (right) of IL-7 for 36 h. Cultures were stained with 
αB220 and αCD43 and analyzed by ﬂ  ow cytometry. Panels represent the number of B220
+CD43
− cell divisions after MODFIT analysis of CFSE histo-
grams. Bars represent the percentage of total cells in each generation relative to parental (Pt) cells. Results are representative of four separate experiments.JCB • VOLUME 179 • NUMBER 4 • 2007  720
To further examine the proliferative capacity of Eμ-myc/
RAG2
−/− versus RAG2
−/− B cell progenitors, we labeled BM 
cells with BrdU, which is incorporated into DNA during cell 
division, and with CFSE. The percentage of B220
+BrdU
+ cells 
is higher in Eμ-myc/RAG2
−/− compared with RAG2
−/− mice 
(Fig. S2 A), and B cells from Eμ-myc/RAG2
−/− mice undergo 
considerably more cell divisions than B cells from RAG2
−/− 
mice in response to IL-7 stimulation (Fig. 3 E). In contrast, 
we do not see any difference in the number of apoptotic B220
+ 
cells between Eμ-myc/RAG2
−/− compared with RAG2
−/− mice 
based on the acquisition of the apoptotic marker annexin V 
(Fig. S2 B).
E𝗍-myc Tg rescues B cell maturation in 
mice deﬁ  cient in Btk and Tec kinases
To further characterize the upstream signaling pathway involved 
in Myc-dependent differentiation, we determined whether Myc 
could rescue B cell differentiation in the absence of the Tec 
family PTKs, which mediate proliferation and differentiation 
downstream of the pre-BCR and BCR (see Fig. 8). We bred 
Eμ-myc mice to mice doubly defi  cient in expression of the Tec 
family PTKs Btk and Tec (Ellmeier et al., 2000). In humans, 
loss of function mutations in the btk gene lead to X-linked 
agammaglobulinemia, an immunological disease whereby Ca
2+ 
signaling is impaired (Fluckiger et al., 1998; for review see 
Rawlings, 1999) and the generation of pre–B cells is blocked. 
In mice, pre–B cell development is only partially inhibited in 
btk-defi  cient mice and proceeds normally in tec-defi  cient mice 
but is essentially completely inhibited in btk/tec double-null 
mice. Thus, we asked whether Myc could rescue B cell develop-
ment when Tec family signaling is ablated. As shown in Fig. 4 A, 
btk
−/−tec
−/− mice are defi  cient in their ability to generate pre–B 
cells based on a reduction in B220
+CD43
− B cell progenitors 
compared with Wt mice. However, when c-myc is expressed in 
btk
−/−tec
−/− B cell progenitors, both the percentage (Fig. 4 A) 
and total number (not depicted) of B220
+CD43
−, B220
+CD22
+, 
and B220
+IA
b+ pre–B cells and B220
+IgM
+ immature B cells 
are completely rescued. These results provide additional genetic 
evidence that Myc stimulates B cell development downstream 
of the pre-BCR and Tec family PTKs.
Figure 2.  Deletion of c- and N-myc results in impaired B1 and B2 B cell development. (A) Splenic B cells from mice of the indicated genotypes (10–11 wk) 
were stained with antibodies to B220, IgM, and IgD. Relative numbers of total B cells (B220
+IgM
+), follicular mature (IgM
loIgD
hi), T2 (IgM
hiIgD
hi), and T1/MZ 
(IgM
hiIgD
lo) B cells were determined as described in Materials and methods. Bars represent the mean ± SEM (error bars) obtained from six CD19cre
− and 
four CD19cre
+ mice. (B) Impaired B1 cell development in c-/N-myc–deﬁ  cient mice. Peritoneal cells were stained with antibodies to B220, IgM, and CD5 
and analyzed by ﬂ  ow cytometry. Numbers in dot plots indicate the percentage of CD5
+IgM
−, CD5
loIgM
hi (B1 B), and CD5
−IgM
hi (B2 B) populations. Data 
are representative of three separate experiments. (C) Decreased antibody production in myc-deﬁ  cient mice. Mice were immunized with KLH-CFA, and the 
KLH-speciﬁ  c serum antibody concentrations were determined by ELISA. Bars represent the mean ± SEM of four Wt and seven CD19cre
+ c-myc
ﬂ  /ﬂ   N-myc
ﬂ  /ﬂ   
mice. Serum dilutions are shown. dKO, double knockout.MYC MODULATES CALCIUM AND B CELL DEVELOPMENT • HABIB ET AL. 721
Loss of Btk and Tec increases the tumor 
frequency in E𝗍-myc transgenic mice
Because Tec kinases have been reported to both induce and 
suppress tumor formation (Hendriks and Kersseboom, 2005), 
we investigated how the transformation capacity of Eμ-myc Tg 
is altered by the loss of Btk and Tec. We find that the hetero-
zygosity of btk and tec is suffi  cient to increase the tumor fre-
quency in Eμ-myc mice, with the 50% tumor incidence being 
reduced from 100 d for Eμ-myc mice to 60 d for Eμ-myc/btk
−/+
tec
−/+ (Fig. 4 B). The percent tumor-free incidence was de-
creased further as additional alleles of btk or tec were deleted. 
These results suggest that deregulated c-myc synergizes with 
the loss of Tec signaling during B cell lymphoma formation. 
Interestingly,  75% of the tumors that develop in Eμ-myc/
btk
−/−tec
−/+ or Eμ-myc/btk
−/−tec
−/− mice express surface IgM 
(unpublished data), indicating that they have an immature 
B cell phenotype relative to the majority of tumors derived from 
Eμ-myc Tg mice, of which >80% are IgM
− pre–B cell tumors 
(Harris et al., 1988).
c-Myc–expressing B cells exhibit elevated 
Ca
2+ levels and NFAT nuclear translocation
Ca
2+ signaling is induced by the pre-BCR and is modulated 
by Btk (for review see Rawlings, 1999), and, in T lymphocytes 
(Aifantis et al., 2001) as well as in many other cell types, is 
required for the induction of differentiation. Because Myc 
rescues B cell differentiation in the absence of the pre-BCR and 
Btk, we investigated whether Myc can bypass requirements for 
normal Ca
2+ signaling or whether Myc amplifi  es Ca
2+ signaling 
in the absence of the pre-BCR or Btk. In B cells, the sustained 
Ca
2+ fl  ux after BCR cross-linking is thought to be caused by 
the concurrent activation of PI3K, which leads to the produc-
tion of membrane-associated PI-3,4,5-P3 and to the recruitment 
and phosphorylation of Btk. Btk activation results in full and 
Figure 3.  c-Myc stimulates B cell development, proliferation, and GL Ig𝗋 transcription in RAG2-null mice. (A) A model of B cell development based on the 
expression of B220, CD43, HSA, CD22, CD25, IA
b, and Igκ (modiﬁ  ed from Hardy and Hayakawa, 2001). (B) c-Myc stimulates pre–B cell–like differentia-
tion in RAG2-null mice. BM cells were stained with αB220, αCD43, αCD22, αCD25, and αIA
b. Representative ﬂ  ow dot plots (of 10 experiments) 
corresponding to mice of the indicated genotypes are shown. (C) BM cells from RAG2
−/− or Eμ-myc/RAG2
−/− mice were stained for the expression of 
B220, CD43, and HSA. Representative histogram overlays of HSA expression on gated B220
+ cells (top), B220
+CD43
+ cells (middle), or B220
+CD43
− 
cells (bottom) are shown. (D) Real-time qPCR analysis of c-myc and Igκ GL message from FACS-sorted B220
+ Eμ-myc/RAG2
−/− and RAG2
−/− B cell 
progenitors. The fold expression ratio (MycRAG2
−/−/RAG2
−/−) of c-myc and Igκ GL mRNA is shown. Bars represent the mean ratio ± SEM (error bars). 
(E) Eμ-myc/RAG2
−/− B220
+ B cell progenitors exhibit increased proliferative capacity compared with RAG2
−/− B cells as assessed by CFSE dilution after 
72-h culture in IL-7 as described in Fig. 1 C. Results are representative of three separate experiments.JCB • VOLUME 179 • NUMBER 4 • 2007  722
sustained PLCγ activation, peak IP3 production, and maximal 
release of [Ca
2+]i (see Fig. 8; for reviews see Rawlings, 1999; 
Hendriks and Middendorp, 2004).
To investigate whether Ca
2+ signaling is affected during 
Myc-dependent differentiation, we labeled total BM cells from 
Eμ-myc Tg and Wt mice as well as Eμ-myc/RAG2
−/− and 
RAG2
−/− mice with the Ca
2+-binding dye indo-1 (June and 
Rabinovitch, 1990) and fl  uorescent-conjugated antibodies against 
B cell markers and measured the ability of B cell progenitors to 
fl  ux Ca
2+ after stimulation with the Ca
2+ ionophore ionomycin 
or anti-IgM. Surprisingly, we fi  nd that B cell progenitors from 
both Eμ-myc Tg and Eμ-myc/RAG2
−/− mice exhibit elevated 
basal [Ca
2+]i and prolonged duration of Ca
2+ fl  ux compared 
with Wt and RAG2
−/− mice, respectively (Fig. 5 A and not 
depicted). Remarkably, Eμ-myc Tg also rescues peak and sus-
tained [Ca
2+]i in B cells (before and after anti-μ stimulation) in 
the absence of Btk and Tec kinases (Eμ-myc Tg/btk
−/−/tec
−/−), 
which are the major mediators of sustained Ca
2+ signaling 
downstream of the pre-BCR (Fig. 5 B). These results suggest 
that Myc amplifi  es [Ca
2+]i signaling in B cells downstream of 
the pre-BCR and Tec kinases.
We next determined whether the elevated Ca
2+ fl  ux we 
observe in Myc-expressing B cells results in changes in known 
nuclear mediators of Ca
2+ signaling. In normal T and B cells, 
Figure 4.  Increased B cell maturation and tumor frequency in E𝗍-myc mice deﬁ  cient in btk/tec kinases. (A) Eμ-myc Tg rescues B cell maturation in 
btk
−/−tec
−/− mice. BM cells isolated from mice of the indicated genotypes (4–6 wk) were analyzed by ﬂ  ow cytometry for the expression of developmentally 
regulated surface markers. Cells falling in the live lymphocyte gate are shown. (B) Absence of Btk/Tec kinases accelerates tumor formation in Eμ-myc 
transgenic mice. Kaplan-Meier tumor-free estimates for mice of the indicated genotypes. Tumor-free survival in Eμ-myc btk
−/−/tec
+/− and Eμ-myc btk
−/−/
tec
−/− mice was signiﬁ  cantly reduced as compared with Eμ-myc mice.MYC MODULATES CALCIUM AND B CELL DEVELOPMENT • HABIB ET AL. 723
Ca
2+ infl  ux activates the phosphatase calcineurin (Cn), which 
dephosphorylates the NFAT family of transcription factors 
(NFATc1–4), allowing them to translocate from the cytoplasm to 
the nucleus and activate transcription of target genes (for reviews 
see Crabtree, 2001; Im and Rao, 2004). We examined the trans-
location of NFAT in purifi  ed splenic B cells from Eμ-myc Tg 
and normal Wt littermates both before and after BCR cross- linking. 
Purifi  ed B cells from Wt littermates require 15 min of anti-IgM 
stimulation to achieve the maximal translocation of NFATc1 
(Fig. 5 C and Fig. S5 C, available at http://www.jcb.org/cgi/  content/
full/jcb.200704173/DC1) and NFATc2 (Figs. 5 D and S5 D) 
to the nucleus. In contrast, B cells from Eμ-myc Tg mice have 
the majority of both NFATc1 and c2 in the nucleus, even before 
stimulation with anti-IgM. These effects are not the result of 
Figure 5.  E𝗍-myc B cells exhibit elevated Ca
2+ ﬂ  ux and enhanced NFATc nuclear translocation. (A) BM cells from Wt, RAG2
−/−, or Eμ-myc/RAG2
−/− mice 
were loaded with indo-1 dye and stained with αB220. Flow kinetics proﬁ  les are shown comparing the mean indo-1 ratio (violet/blue) of B220
+ (top) and 
B220
− (bottom) cells as a function of time before and after stimulation with ionomycin. (B) Eμ-myc Tg rescues Ca
2+ ﬂ  ux in Btk/Tec-null B cell progenitors. 
BM cells from mice of the indicated genotypes were loaded with indo-1 and stained with αB220 and αCD43. Kinetics proﬁ  les comparing the indo-1 
ﬂ  uorescence ratio of B220
+ cells as a function of time before and after stimulation with anti-μ are shown. (C–F) B cells from Eμ-myc, Eμ-myc/RAG2
−/−, 
and Eμ-myc/btk
−/−tec
+/− mice exhibit enhanced nuclear localization of NFATc. Cytoplasmic and nuclear extracts were prepared from splenic B cells 
stimulated with anti-μ for the indicated times (C, D, and F) or unstimulated puriﬁ  ed B cell progenitors (E) and were size fractionated by SDS-PAGE. Western 
blot analysis was performed with αNFATc1 (C, E, and F) or αNFATc2 (D) or with loading controls β-actin (C–F), α-lamin (C–E), or α-Max (F). Adjacent panels 
depicted in D or E are from the same gel. White lines indicate that intervening lanes have been spliced out. R
−/−, RAG2
−/−; M/R
−/−, Eμ-myc/RAG2
−/−. 
NFAT isoforms are indicated by brackets or arrowheads.JCB • VOLUME 179 • NUMBER 4 • 2007  724
 increased NFAT expression in Eμ-myc B cells, as NFATc mRNA 
(Fig. S4 A) and protein levels (Fig. S5, A and B) are reduced or 
unchanged relative to Wt B cells. Myc expression also results 
in substantially increased nuclear NFATc1 translocation in un-
stimulated B cell progenitors from Eμ-myc/RAG2
−/− compared 
with RAG2
−/− mice (Figs. 5 E and S5 E) and rescues NFAT 
translocation in splenic B cells from Eμ-myc/btk
−/−tec
−/+ as 
compared with btk
−/−tec
−/+ mice (Figs. 5 F and S5 F). Trans-
fection of Myc-null fi  broblasts (HO.15 cells) with c-Myc (Shiio 
et al., 2002) results in greatly enhanced NFAT activity based on 
increased activation of an NFAT-luciferase reporter construct 
(Fig. S3 E), demonstrating that Myc also increases NFAT activity. 
These results suggest that the sustained increase in [Ca
2+]i sig-
naling in Myc-expressing B cells has a major infl  uence on key 
Ca
2+-regulated nuclear events.
To assess whether the elevated Ca
2+ fl  ux in Myc-expressing 
B cell progenitors may contribute to the abilities of Myc to 
stimulate maturation and proliferation, we fi  rst determined how 
[Ca
2+]i levels in these mice correlate with differentiation, prolif-
eration, and survival status. We fi  nd that Ca
2+ levels positively 
correlate with maturation and proliferation in Eμ-myc/RAG2
−/− 
mice based on the down-regulation of CD43 on B220
+ cells and 
dilution of CFSE. B cell progenitors with the most mature 
phenotype (B220
+CD43
−) and highest proliferative capacity 
have the highest levels of Ca
2+ fl  ux, whereas the cells with the 
least mature phenotype (B220
+CD43
hi–mid) and lowest prolifer-
ative capacity have the lowest levels of Ca
2+ fl  ux (Fig. S3, A–C). 
The observed increase in [Ca
2+]i is not the result of differ-
ences in cell cycle status because gated G0/G1 cells from 
Eμ-myc Tg have consistently elevated [Ca
2+]i relative to G0/G1 
cells from normal littermates (Fig. S3 D). These results suggest 
that there is a correlation between amplifi  ed Ca
2+ signaling 
and the ability of Myc-expressing B cells to undergo differenti-
ation and division.
We next examined whether normal Ca
2+ signaling is re-
quired for maturation and division of Wt and Myc Tg pre–B 
cells. First, we determined whether impairing endogenous Myc 
expression results in impaired Ca
2+ fl  ux. Total BM cells from 
N-myc
fl / fl  c-myc
fl  /fl   CD19cre
− or CD19cre
+ mice were stimulated 
in vitro with anti-μ for 2 h to induce myc expression followed 
by ionomycin stimulation to induce Ca
2+ fl  ux. As shown in 
Fig. 6 A, both pre–B/immature B and mature B cell populations 
from N-myc
fl  /fl   c-myc
fl  /fl   CD19cre
+ mice exhibit reduced peak 
and sustained Ca
2+ levels relative to CD19cre
− mice. To deter-
mine whether a reduction of Ca
2+ levels affects the ability of both 
Wt and Eμ-myc cells to proliferate and mature, we cultured 
  total BM cells from Wt and Myc Tg mice in EGTA to limit the 
amount of available extracellular Ca
2+ and assessed maturation 
and proliferative capacity after the addition of increasing doses 
of extracellular Ca
2+. As shown in Fig. S4 (B and C), chelation 
of Ca
2+ with EGTA results in the impairment in Ca
2+ fl  ux and 
proliferative capacity after ionomycin stimulation. EGTA also 
blocks the ability of Wt B cell progenitors to mature from the 
B220
+CD43
+ stage to the B220
+CD43
− stage (Fig. 6 B, fi  rst 
and second panels), which is rescued by the addition of extra-
cellular Ca
2+ (Fig. 6 B, third to fi  fth panels). B cell progenitors 
were unable to divide in low Ca
2+ conditions based on limited 
CFSE dilution of live (TO-PRO-3) cells (Fig. 6 C, fi  rst and second 
panels), which is also rescued by the addition of extracellular 
Ca
2+ (Fig. 6 C, third to fi  fth panels). Progenitors from Eμ-myc/
RAG2
−/− mice were also unable to mature (Fig. S4 D) or divide 
effi  ciently (not depicted) under low Ca
2+ conditions.
As Eμ-myc B cells exhibit increased NFAT nuclear trans-
location, we also determined whether the Cn–NFAT pathway is 
required for the division of Wt and Eμ-myc B cells. Purifi  ed B 
cells from Wt and Eμ-myc mice were stimulated with anti-μ for 
72 h in the presence or absence of cyclosporine A (CsA), a specifi  c 
inhibitor of Cn. As shown in Fig. 6 D, Wt B cells undergo an aver-
age of four divisions (Fig. 6 D, left), and Eμ-myc B cells undergo 
an average of fi  ve divisions (Fig. 6 D, right) in response to anti-μ, 
whereas cell division is completely inhibited by CsA. Collec-
tively, these results suggest that normal Ca
2+ signaling is required 
for pre-BCR–mediated pre–B cell proliferation and maturation 
and for Myc to stimulate the differentiation of B cell progenitors.
Myc regulates Ca
2+ efﬂ  ux
The increase in [Ca
2+]i that occurs in response to stimuli such as 
BCR ligation is transient, in part because Ca
2+ is resequestered 
into the endoplasmic reticulum by the sarcoplasmic ER Ca
2+ 
ATPase (SERCA) or is extruded from the cell by plasma mem-
brane Ca
2+-ATPase (PMCA) pumps. Because Myc amplifi  es 
[Ca
2+]i in B cells in the absence of Btk and Tec (which regulate 
infl  ux), we hypothesized that Myc could be altering the extent 
of Ca
2+ effl  ux. First, we measured the relative expression of 
PMCA1, PMCA4, and SERCA3, the respective pumps expressed 
in B lineage cells (Chen et al., 2004). Although we did not fi  nd 
consistent differences in the expression of PMCA1 and serca3 
in mature B cells from Eμ-myc mice relative to Wt mice (un-
published data), levels of PMCA4 mRNA are signifi  cantly 
decreased in Eμ-myc mature B and Eμ-myc/RAG2
−/− pro–B 
cells (Fig. 7 A), whereas PMCA4 mRNA is increased in sorted 
pro–B cells from N-myc
fl / fl  c-myc
fl / fl  CD19cre
+ versus CD19cre
− 
mice (Fig. S4 E). The decrease in PMCA4 expression correlates 
with a decrease in total PMCA protein (Fig. 7 B) and export 
of Ca
2+ across the plasma membrane in purifi  ed B cells from 
Eμ-myc mice relative to Wt mice in response to anti-μ (Fig. 7 C), 
as measured by fl  uorometric analysis of extracellular media 
containing a membrane-impermeable version of the Ca
2+-binding 
Indo-1 dye. These results suggest that Myc negatively regulates 
Ca
2+ extrusion in B cells and are consistent with a recent report 
that Myc interacts with the human PMCA4b promoter, resulting 
in decreased PMCA4b expression (Zeller et al., 2006). Indeed, 
we also fi  nd using chromatin immunoprecipitation (ChIP) that 
Myc interacts within the homologous region in the mouse PMCA4 
promoter (Fig. S4 F).
To determine whether reduced PMCA4b expression in 
Myc-expressing cells is important for Myc-induced prolifera-
tion, we infected BM cells from Wt or Eμ-myc mice with murine 
stem cell virus (MSCV) retroviruses containing internal ribo-
somal entry site (IRES)–GFP and human PMCA4b cDNA (MSCV-
PMCA4b-GFP) or vector alone (MSCV-GFP). Analysis of the 
Phoenix retroviral packaging cell line indicates that MSCV-PM-
CA4b-GFP
+ cells exhibit a substantially decreased baseline and 
peak [Ca
2+]i after ionomycin stimulation relative to GFP
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whereas MSCV-GFP
+ cells fl  ux normally (Fig. 7 D). Infection 
of Wt and Eμ-myc BM with MSCV-PMCA4b-GFP virus results 
in increased hPMCA4b expression over MSCV-GFP–infected 
cells by real-time PCR (Fig. 7 E). MSCV-GFP–infected Wt and 
Eμ-myc pre–B cells (B220
+GFP
+) divide normally in response 
to IL-7 in vitro based on considerable dilution of the CFSE-like 
SNARF-1 dye. In contrast, B cell proliferation is inhibited in 
MSCV-PMCA4b-GFP–infected Wt and Eμ-myc B cells in a dose-
dependent manner (Fig. 7 F and not depicted).
Discussion
Myc stimulates B lymphocyte development
The roles of Myc proteins in cell differentiation remains one 
of the most controversial issues in Myc biology. Early studies 
performed in cell lines and more recent studies in primary keratino-
cytes resulted in the prevailing view that Myc stimulates cell cycle 
entry while inhibiting differentiation (for review see Pelengaris 
et al., 2002). However, in primary chicken and murine B cells 
engineered to overexpress myc and in humans with Burkitt’s 
lymphoma, B lymphocytes mature to the Ig
+ B cell stage rela-
tively unperturbed despite the constitutive overexpression of myc 
throughout B cell development (Langdon et al., 1986; Thompson 
et al., 1987). These results suggest that B cells are able to mature 
relatively normally despite the presence of deregulated Myc.
In this study, we took a genetic approach to address the 
roles of Myc in the differentiation of mammalian cells using 
primary B cells. First, we found that conditional myc deletion 
signifi  cantly inhibits B cell development at the pro–B to pre–B 
cell transition (Fig. 1 B), which is the stage at which the combined 
Figure 6.  Calcium signaling is required for pre–B cell development and for Myc-mediated maturation of RAG2-null pro–B cells. (A) BM cells from the indi-
cated mice were loaded with indo-1, stained with αB220 and αCD43, and preincubated with anti-μ for 2–3 h to up-regulate myc. (left) Representative 
kinetics proﬁ  le comparing the mean indo-1 ratio versus time after stimulation of anti-μ–pretreated cells with ionomycin. (right) Bars represent the mean 
ﬂ  uorescence ratio ± SEM (error bars) after ionomycin-stimulated Ca
2+ ﬂ  ux of B220
loCD43
− BM cells (left; n = 4 mice/group) or B220
hiCD43
− cells (right; 
n = 6 mice/group). (B) Wt BM cells were stained with CFSE and cultured for 48 h with IL-7 in the presence or absence of 1 mM EGTA and the indicated 
concentrations of CaCl2. Representative histograms of CD43 expression on gated B220
+ cells are shown. (C) IL-7–induced proliferation of CFSE-stained 
cultures from B. CFSE dilution histograms of gated B220
+ TO-PRO-3
− cells are shown. Results are representative of three separate experiments. (B and C) 
The vertical dotted lines denote an equivalent location on the x axis of each panel for orientation. (D) The Cn–NFAT pathway is required for the proliferation 
of Wt and Eμ-myc B cells. Splenocytes from Wt (left) or Eμ-myc (right) mice were stained with CFSE and cultured with anti-μ in the presence or absence of 
CsA for 72 h. Panels represent the number of B220
+ cell divisions after MODFIT analysis. Results are representative of two separate experiments.JCB • VOLUME 179 • NUMBER 4 • 2007  726
signaling from the pre-BCR and IL-7 normally induce c- and 
N-myc expression. Second, to distinguish the ability of Myc to 
drive the proliferation of postdifferentiated cells from its ability 
to initiate a differentiation program, we asked whether Myc could 
rescue differentiation on two genetic backgrounds (RAG2
−/− and 
btk
−/−/tec
−/−) whereby B cell development is blocked just before 
the stages at which c- and N-myc are normally expressed. We found 
that the Eμ-myc Tg effi  ciently stimulated the differentiation 
and expansion of pre–B-like cells from pro–B cells in the ab-
sence of pre-BCR formation (in RAG2
−/− mice). Additionally, 
Figure 7.  Reduced PMCA expression in E𝗍-myc B cells correlates with decreased Ca
2+ efﬂ  ux and increased proliferation. (A) Real-time PCR analysis of 
c-myc and PMCA4 message from puriﬁ  ed splenic B cells (top) or pro–/pre–B-like cells (bottom). The fold expression ratio (Eμ-myc/Wt or Eμ-myc–RAG2
−/−/
RAG2
−/−) of c-myc and PMCA4 message is shown. Values represent the mean ± SEM obtained from three (top) or two experiments (bottom). (B) Reduced 
PMCA protein in unstimulated and anti-μ–treated Eμ-myc splenic B cells correlates with decreased cytoplasmic NFATc1 (increased NFATc1 nuclear 
translocation) as compared with Wt littermate controls. Cytoplasmic extracts were analyzed by immunoblotting. (C) Ca
2+ efﬂ  ux from splenic B cells puriﬁ  ed 
from Eμ-myc and Wt mice measured before and after stimulation with anti-μ (arrow). A representative kinetics proﬁ  le (Ca
2+ extrusion rate) comparing the 
extracellular indo-1 ﬂ  uorescence ratio as a function of time is shown. (D) The enforced expression of PMCA4b results in impaired Ca
2+ ﬂ  ux. MSCV-GFP 
and MSCV-PMCA4b-GFP–transfected Phoenix cells were loaded with indo-1 after collecting viral supernatants for the infection of BM cultures depicted in F. 
Flow cytometric kinetics proﬁ  les of MSCV-GFP control (top) and MSCV-PMCA4b-GFP (bottom) cells comparing Ca
2+ mobilization of GFP
− versus GFP
+ 
cells as a function of time before and after stimulation with ionomycin. (E) RT-PCR analysis conﬁ  rming the speciﬁ  c expression of human PMCA4 message 
from MSCV-PMCA4b-GFP–infected Wt and Eμ-myc BM depicted in F. hprt was ampliﬁ  ed as a loading control. (F) The enforced expression of PMCA4b 
inhibits the proliferation of Wt and Eμ-myc BM B cells. BM cells infected with MSCV-GFP or MSCV-PMCA4b-GFP were labeled with SNARF-1 and cultured 
in the presence of IL-7 for 48 h. Cultures were stained with αB220 and analyzed by ﬂ  ow cytometry. Single-parameter SNARF-1 dilution histograms of gated 
B220
+GFP
+ cells are shown. Results are representative of two separate experiments.MYC MODULATES CALCIUM AND B CELL DEVELOPMENT • HABIB ET AL. 727
we found that Myc can rescue B cell development to the IgM
+ 
immature B cell stage in the context of a btk
−/−/tec
−/− back-
ground, whereby B cell development is nearly completely 
blocked at the large pre–B cell stage. These results collectively 
provide genetic evidence that Myc acts downstream of the 
pre-BCR and Btk/Tec to stimulate pre–B cell development 
and are consistent with previous studies suggesting that the pre-
BCR is required for myc induction and pre–B cell development 
(Zimmerman and Alt, 1990; for review see Hendriks and 
Middendorp, 2004).
The notion that Myc may initiate differentiation was fi  rst 
proposed by Gandarillas and Watt (1997) in keratinocytes 
in vitro. Recent studies have suggested roles for Myc in inducing 
the differentiation of hematopoietic and epidermal stem cells, in 
part by regulating the expression of adhesion molecules, thus 
releasing them from a differentiation-inhibiting niche (Murphy 
et al., 2005). In this study, we show that constitutive Myc can 
act in a cell-autonomous manner to rescue differentiation in 
lineage-committed progenitor cells. These results collectively 
suggest that the phenotypic consequences of Myc during devel-
opment may depend on the differentiation status of the cell: Myc 
expression in stem cells and lineage-committed progenitors 
results in differentiation, whereas Myc expression in mature 
postmitotic cells results in reentry into the cell cycle and in-
hibition of terminal differentiation.
Deregulated Myc synergizes with 
the loss of Tec kinase function during 
lymphoma formation
Although btk-null or btk/tec double-null mice do not sponta-
neously develop pre–B cell tumors, the absence of both btk 
and SLP-65 signifi  cantly enhances the incidence of pre–B cell 
leukemia as compared with SLP-65–null mice (Hendriks and 
Kersseboom, 2005). Although the exact mechanism of tumor 
suppression by Tec family PTKs is not known, the loss of Btk and/
or SLP-65 in B cells results in sustained IL-7 receptor (IL-7R) 
expression and an increased proliferative and/or survival response 
to IL-7. Here, we show that loss of Btk/Tec signifi  cantly accel-
erates B cell tumor formation in Eμ-myc mice (Fig. 4 B). In addi-
tion, we fi  nd that Eμ-myc Tg substantially increases the proliferative 
potential of B cell progenitors in response to IL-7, whereas 
decreasing myc expression inhibits IL-7–mediated prolifera-
tion. Thus, sustained IL-7R expression in tec/btk-null mice, in 
cooperation with constitutive Myc activity as occurs in Burkitt’s 
lymphoma, substantially increases the pool of dividing cells 
that is capable of acquiring epigenetic alterations that promote 
tumorigenesis. We conclude that Tec PTKs act as tumor sup-
pressors that attenuate deregulated c-myc and that IL-7 syner-
gizes with Myc to increase the pool of dividing B cell progenitors. 
The ability of Myc to drive differentiation to the IgM-positive 
stage in Btk
−/−/Tec
−/− mice while having accelerated trans-
formation further suggests that it is not the inhibition of matu-
ration itself but rather the degree of growth factor responsiveness 
that determines tumor susceptibility. Consistent with the latter 
notion, loss of Jak3 kinase, an essential IL-7 signaling molecule, 
reduces the transforming potential of the Eμ-myc Tg (Dillon 
and Schlissel, 2002).
Myc regulates Ca
2+ signaling and NFAT 
translocation during B cell development
Because Ca
2+ signaling is important for virtually all aspects of 
embryogenesis (for review see Webb and Miller, 2003) and 
pre-BCR and Btk stimulate Ca
2+ signaling pathways, we were 
prompted to investigate how Ca
2+ signals were affected during 
Myc-dependent B cell development. Surprisingly, we found 
that both basal [Ca
2+]i levels and the duration of Ca
2+ fl  ux are 
elevated in B cells from Eμ-myc Tg and Eμ-myc/RAG2
−/− 
mice. Furthermore, an increase in the relative level of [Ca
2+]i in 
Eμ-myc/RAG2
−/− Tg mice positively correlates with increased 
proliferation and differentiation and is required for Myc to 
stimulate B cell development and proliferation. The increase in 
[Ca
2+]i level may occur by down-regulation of the Ca
2+ effl  ux 
pump PMCA4b because Myc interacts with the PMCA4b 
promoter, and both PMCA4b expression and Ca
2+ effl  ux are 
decreased in Eμ-myc B cells. Moreover, enforced PMCA4b 
expression inhibits Myc-induced cell proliferation. These results 
are consistent with a study in developing T lymphocytes in the 
thymus, which depend on Ca
2+ signaling during the maturation 
and expansion of CD4
−CD8
− pre–T cells after rearrangement 
of the T cell receptor β chain and formation of the pre–T cell 
receptor (Aifantis et al., 2001). In addition, gene-targeted muta-
tions in other genes involved in Ca
2+ signaling, including the 
Src family PTKs Lyn/Fyn/Blk, Syk, SLP-65, LAT (linker for 
activation of T cells), Btk/Tec, the p85 subunit of PI3K (Fruman 
et al., 1999), and PLCγ1/2 (Wen et al., 2004), also result in 
impaired B cell development at the pre–B cell stage. Altogether, 
these results strongly support a role for Myc and Ca
2+ signaling 
in the maturation of pre–B cells.
A study in primary B lymphocytes indicates that the 
 amplitude and duration of Ca
2+ signals have profound infl  uences 
on the type of transcriptional response (Dolmetsch et al., 1997). 
For example, NF-κB and JNK are selectively activated by a large 
transient [Ca
2+]i rise, whereas NFAT is activated by lower but 
sustained [Ca
2+]i levels. We also fi  nd that B cells from Eμ-myc 
Tg mice, which exhibit elevated, sustained [Ca
2+]i levels, also 
exhibit increased NFAT translocation even in the absence of 
upstream signals from the pre-BCR and BCR. In addition, B cell 
nuclear fractions from Myc Tg mice appear to contain mostly 
the short isoform of NFATc1 (NFATc1A; Fig. 5), which, in con-
trast to the other NFATc1 isoforms (NFATc1B and c1C), does 
not promote apoptosis in lymphocytes (Chuvpilo et al., 2002). 
These results suggest that the elevated [Ca
2+]i in Myc-expressing 
B cells has profound infl  uences on transcriptional and biological 
responses as well. Indeed, we fi  nd that anti-IgM–induced B cell 
proliferation of both Wt and Myc Tg B cells is completely ab-
rogated by treatment of cells with CsA, and a recent study indi-
cates that the B cell–specifi  c deletion of Cn results in defects in 
B cell proliferation and function (Winslow et al., 2006).
Implications of Myc-regulated Ca
2+ signaling
One common feature of many types of cancers is their reduced 
dependence on external growth factors, and Myc-induced tumors 
share this property. Indeed, Myc activates at least three genetic 
programs that are normally growth factor dependent, including 
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synthesis pathways (for review see Eisenman, 2001). How can 
one transcription factor with limited target gene specifi  city 
induce so many biochemical and biological changes that are nor-
mally dependent on multiple signaling pathways? Our results 
suggest that although Myc directly stimulates the expression of 
many E box–containing genes, Myc also increases sustained 
[Ca
2+]i and enhances NFAT translocation (Fig. 8). This allows for 
the concurrent activation of Ca
2+-dependent target genes even in 
the apparent absence of upstream mediators of Ca
2+ signaling, as 
might occur under conditions of poor growth factor availability 
Figure 8.  Model of Myc and Ca
2+ signaling events downstream of the pre-BCR/BCR. Engagement of the pre-BCR/BCR results in the recruitment of Src family 
kinases (Blk, Lyn, and Fyn), phosphorylation of the Igα–Igβ complex, and formation of a Ca
2+ signaling module containing SLP-65, PI3K, Btk/Tec, and 
PLCγ. Full activation of PLCγ by Btk results in IP3-mediated Ca
2+ release from the ER, resulting in activation of the Cn–NFAT signaling pathway. PKCβ activation 
by Ca
2+ and DAG leads to the nuclear translocation of NF-κB and the induction of myc expression. Our results implicate Myc in amplifying [Ca
2+]i 
by decreasing PMCA4-mediated Ca
2+ efﬂ  ux, thereby promoting optimal NFAT-dependent proliferation, differentiation, and immunogenic B cell responses. 
Induction of low level Ca
2+ signals or Myc signaling alone results in a tolerogenic and/or apoptotic response, whereas Myc activation together with 
sustained Ca
2+/NFAT signals or constitutive Myc signaling alone promotes B cell activation/differentiation or tumorigenesis.MYC MODULATES CALCIUM AND B CELL DEVELOPMENT • HABIB ET AL. 729
or limited extracellular Ca
2+. The synergy between Myc and [Ca
2+]i 
to stimulate B cell development and proliferation are strik-
ingly similar to the signaling requirements underlying immuno-
genic versus tolerogenic responses to antigen in B lymphocytes. 
Although activation of Myc alone or a low level Ca
2+ signal alone 
provokes apoptosis or anergy (tolerance; Glynne et al., 2000), 
Myc expression in conjunction with a sustained Ca
2+/NFAT signal 
results in a mitogenic response and immunity. Here, we fi  nd that 
Myc amplifi  es [Ca
2+]i, thus tuning levels into the range required 
for optimal NFAT activation and translocation. The unique func-
tion of Myc to amplify Ca
2+ signaling may help explain why 
transformed cells are relatively resistant to low growth factor and 
Ca
2+ conditions (Whitfi  eld, 1992) despite known requirements 
for Ca
2+ signaling during G1→S transition.
Materials and methods
Mice
C57BL/6 Eμ-myc transgenic mice were obtained from Jackson Immuno-
Research Laboratories and were genotyped by PCR according to instructions 
from the supplier. To generate mice carrying conditionally inactivated 
c- and N-myc genes, mice carrying a ﬂ   oxed c-myc allele (c-myc
ﬂ / ﬂ ; 
de Alboran et al., 2001) were bred to N-myc
ﬂ  /ﬂ   mice (Knoepﬂ  er et al., 
2002) expressing the cre recombinase Tg under the control of the CD19 
promoter (Rickert et al., 1997). btk/tec-deﬁ  cient mice have been described 
previously (Ellmeier et al., 2000). Mice were housed under speciﬁ  c pathogen-
free conditions. All mouse procedures were approved by the University of 
Washington Institutional Animal Care and Use Committee.
Cell culture
For cell division experiments, cells were stained with CFSE according to the 
manufacturers’ instructions (Invitrogen). CFSE-labeled cells were cultured 
in complete RPMI + 10% FBS (Hyclone) in the presence or absence of 
10 ng/ml murine recombinant IL-7 (R&D Systems) or 5 μg/ml anti-μ (F(ab’)2 
fragment; Thermo Fisher Scientiﬁ  c) for the indicated times at 37°C and 
5% CO2. In some experiments, EGTA was added at a ﬁ  nal concentration 
of 0.5, 0.75, or 1 mM to IL-7–driven cultures in the presence or absence 
of 0.2, 0.4, or 0.6 mM CaCl2, and cyclosporine was added at a ﬁ  nal con-
centration of 100 ng/ml to anti-μ–driven cultures. Thereafter, the cells were 
stained with the indicated antibodies for analysis by FACS or harvested for 
measurement of [Ca
2+]i (see section Measurement of intracellular calcium 
and DNA content). The vital dye TO-PRO-3 (Invitrogen) was added to the 
indicated samples (1-nM ﬁ  nal concentration) before acquisition to distin-
guish live and apoptotic cells. The number of discrete CFSE peaks was 
determined using MODFIT software (Verity Software House).
The Myc-null and Myc-expressing ﬁ  broblast cell lines HO.15 and 
HO.15 + c-Myc, respectively, and the Phoenix packaging cell line were 
grown in DME supplemented with 10% FCS, glutamine, penicillin, strepto-
mycin, and essential amino acids. For retroviral gene transfer into primary 
BM cells, human PMCA4b cDNA was subcloned into the HpaI site of 
the modiﬁ  ed MSCV MIG vector upstream of the EGFP gene and IRES. The 
MSCV vector carrying only the IRES-EGFP cassette was used as a control. 
The cDNA of human PMCA4b was provided by M. Husain (Department of 
Physiology, University of Toronto, Toronto, Canada; Heim et al., 1992). 
Ecotropic viral stocks were generated by Ca
2+ phosphate–mediated trans-
fection of subconﬂ  uent Phoenix cells in the presence of chloroquine. Viral 
supernatant was collected and ﬁ  ltered after 3 d. For infection of Wt or Myc 
Tg BM,  15 × 10
6 cells were plated per well of a six-well plate and in-
fected 48 h later with 4 ml of fresh viral supernatant and 4 μg/ml poly-
brene by spinoculation. Two rounds of infection were performed, and cells 
were then labeled with 1 μM SNARF-1 (S-22801; Invitrogen) for 15 min at 
room temperature. Cells were washed twice with complete RPMI + 10% 
FCS and cultured in fresh medium containing 10 ng/ml IL-7 for an addi-
tional 48 h. Thereafter, the cells were stained with αB220-phycoerythrin 
(PE) for analysis of B220
+ GFP
+ cell division by FACS.
Flow cytometric analysis
Single-cell suspensions were prepared and analyzed by ﬂ  ow cytometry as 
previously described (Iritani et al., 1997). The majority of antibodies used in 
this study are referenced in Iritani et al. (1997). Additional antibody   conjugates 
used in this study include B220-PE-Cy-5.5 (eBioscience), FITC anti–mouse 
CD21, biotin anti–mouse CD22.2, biotin anti–mouse IA
b (BD Biosciences), 
FITC–annexin V (Invitrogen), IgM-PE-Cy7 (SouthernBiotech), and IgD-FITC (BD 
Biosciences). Cytometry was performed on FACScan and LSR ﬂ  ow cyto  meters 
(BD Biosciences). Data were analyzed using CellQuest (Becton Dickinson) 
and FlowJo (version 6.3.2; Tree Star, Inc.) softwares. To determine relative 
numbers of B lineage cells in each population (Fig. 1 B), percentages from 
ﬂ  ow cytometry were multiplied by the total BM cellularity to obtain absolute 
numbers of pro–B cells (B220
+CD43
+), pre–B cells (B220
+CD43
−), im-
mature B cells (B220
loIgM
+), and mature B cells (B220
hiIgM
+). To deter-
mine relative numbers of peripheral B2 B cells in each population (Fig. 2 A), 
percentages from ﬂ  ow cytometry were multiplied by the total spleen cellularity 
to obtain absolute numbers of total B cells (B220
+IgM
+), follicular mature 
(IgM
loIgD
hi), T2 (IgM
hiIgD
hi), and T1/MZ (IgM
hiIgD
lo) B cells.
Measurement of intracellular Ca
2+ and DNA content
For measurement of [Ca
2+]i, cells were washed and resuspended in 0.5 ml 
HBSS containing 3% FBS at 10
6–10
7 cells/ml (for harvested BM cultures) or 
5 × 10
7–8 × 10
7 cells/ml (for freshly isolated BM). EGTA-treated cell cultures 
were resuspended in Ca
2+-free HBSS/3% FBS. Indo-1–acetoxymethyl (penta-
acetoxymethyl ester; Sigma-Aldrich) was added at a ﬁ  nal concentration of 
10–20 μM, and incubation was performed for 30 min at 37°C. The indo-1 
ﬂ  uorescence ratio (400:530 nm) of the cells was acquired as a function of 
time using a ﬂ  ow cytometer (BD-LSR I; Becton Dickinson). For each experi-
ment, collection of a 30-s baseline measurement was followed by stimulation 
with either 25 μg/ml anti-μ or 1 μg/ml ionomycin (EMD) as indicated. For 
pre-BCR cross-linking of c- and N-myc–deﬁ  cient or Wt BM, indo-1–loaded 
cells were ﬁ  rst preincubated with 25 μg/ml anti-μ for 2–3 h at 37°C.
For simultaneous analyses of Ca
2+ ﬂ   ux and DNA content, ﬂ  uo-4 
Ca
2+-binding dye (Invitrogen) was added at a ﬁ  nal concentration of 1 μM in 
place of indo-1–acetoxymethyl. The cells were washed twice with HBSS/3% 
FBS and stained with the indicated antibody conjugates at room tempera-
ture for 45 min followed by Hoescht (Invitrogen) for 45 min at 37°C. There-
after, the cells were washed twice, resuspended in a 1–2-ml ﬁ  nal volume, 
and maintained at 37°C for 5 min before and during analysis of [Ca
2+]i.
Measurement of extracellular Ca
2+ [Ca
2+]o
Ca
2+ efﬂ  ux was measured with a cell-impermeable form of indo-1 (5-μM 
ﬁ  nal concentration; Invitrogen). 10
7 puriﬁ  ed splenic B cells were washed 
twice with Na
+-free/Ca
2+-free efﬂ  ux buffer (modiﬁ  ed from Chen et al., 
2004) and resuspended in 2 ml efﬂ  ux buffer (10 mM Hepes, pH 7.4, 1 mM 
MgCl2, 5 mM KCl, 135 mM choline chloride, 10 mM glucose, and 0.1% BSA). 
Fluorescence of cell suspensions was detected with a Fluorescence Master 
Series ﬂ  uorometer (Photon Technology International) at an excitation wave-
length of 350 nm and emission wavelengths of 400 and 485 nm. Collection 
of a baseline measurement was followed by stimulation with 10 μg/ml 
anti-μ (F(ab’)2 fragment), and ratiometric Ca
2+ values (400:485 nm) were 
plotted as a function of time.
Reporter gene assays
For NFAT-luciferase assays, HO.15 (Myc null) or HO.15 + c-Myc ﬁ  broblasts 
were plated in 24-well tissue culture dishes at 90% conﬂ  uence and, 24 h 
later, were transfected in triplicate with pNFAT-luciferase plasmid or pCIS-
CK negative control plasmid containing the luciferase reporter gene with-
out any cis-acting elements (Stratagene) and the pRL Renilla luciferase 
control reporter vector (Promega) using LipofectAMINE (Invitrogen) according 
to the manufacturer’s instructions. Treatment with 60 ng/ml PMA + 1 μg/ml 
ionomycin or PMA/ionomycin + 100 ng/ml CsA was performed 18 h 
  after transfection. After 6 h, luciferase assays were performed with a lumi-
nometer (Monolight 1500; Analytical Luminescence Laboratories) and the 
Dual Luciferase Reporter assay system (Promega). Fireﬂ  y luciferase values 
for each transfection were normalized to Renilla luciferase activity (pRL), 
and data were expressed as relative luciferase activity versus that obtained 
with the pCIS-CK negative control plasmid. Mean values of a representa-
tive experiment of three performed are displayed ± SEM.
In vivo BrdU labeling
Mice were given water containing 0.8 mg/ml BrdU (Sigma-Aldrich) for 2 d. 
BM was harvested, surface stained for B220, and ﬁ  xed, permeabilized, 
and treated with 30 μg DNase I (Sigma-Aldrich). Incorporation of BrdU 
into DNA was measured by ﬂ  ow cytometry using anti–BrdU-FITC (BD Bio-
sciences) according to the manufacturer’s protocol.
B cell puriﬁ  cation
Single-cell suspensions of total splenocytes and BM cells were isolated as 
previously described (Iritani et al., 1997). B lymphocytes were enriched by JCB • VOLUME 179 • NUMBER 4 • 2007  730
negative selection on magnetic microbeads coupled to rat anti–mouse 
CD43 (Miltenyi Biotec) or using the mouse B cell Negative Isolation kit 
  (Invitrogen) according to protocols provided by the manufacturers. The re-
covered splenic B cells were rested in RPMI 1640 medium before stimula-
tion for biochemical analyses or were washed into efﬂ  ux buffer for Ca
2+ 
efﬂ  ux assays. B lineage cells were enriched from total BM by positive selec-
tion on magnetic beads coupled to CD45R/B220 (Invitrogen) or CD19 
(Miltenyi Biotec) according to the manufacturers’ instructions or by cell sort-
ing on a FACSaria (BD Biosciences).
Western blot analysis
Puriﬁ  ed splenic B cells were stimulated with 25 μg/ml anti-μ (F(ab’)
2 fragment) in serum-free RPMI medium. At the indicated time points, the 
cells were washed twice in ice-cold PBS and resuspended in hypotonic buf-
fer  containing protease inhibitors. Cytoplasmic and nuclear extracts 
were prepared by the method of Dolmetsch et al. (1997). SDS-PAGE and 
Western blotting were performed using standard techniques. Anti-NFATc1, 
anti-NFATc2, anti–β-actin, anti-Max, and donkey anti–goat IgG-HRP 
were purchased from Santa Cruz Biotechnology, Inc. Rabbit anti–mouse 
IgG HRP secondary antibody was purchased from Invitrogen. Goat anti–
rabbit IgG HRP secondary antibody was purchased from Bio-Rad Labora-
tories. Anti-PMCA monoclonal antibody (clone 5F10) was purchased 
from Millipore. Anti–lamin A/C antibody was purchased from Cell Signal-
ing Technology. Anti–α-tubulin monoclonal antibody was purchased from 
Sigma-Aldrich.
ChIP
Puriﬁ  ed splenic B cells from Myc Tg mice were cross-linked with 1% formal-
dehyde for 10 min at 37°C. ChIP was performed with the ChIP assay kit 
(Millipore) according to the manufacturer’s instructions using anti–c-Myc 
(N-262; Santa Cruz Biotechnology, Inc.) or control rabbit IgG (rIgG; Santa 
Cruz Biotechnology, Inc.) antibodies. After reversal of cross-links, DNA 
was precipitated and detected by qPCR with pairs of primers (underlined) 
speciﬁ  c to the mouse PMCA4b promoter (189-bp region beginning at 
–2,872 relative to the putative transcription start site and –4,285 relative 
to the translation start site: 5′-T  A  G  G  A  G  C  A  A  G  C  T  C  A  G  C  A  G  T  T  A  G  C  A  A  G  C-
G  C  T  C  A  C  G  T  T  C  T  A  G  A  A  A  C  T  T  G  T  G  T  G  T  C  C  C  T  C  A  G  T  G  C  A  G  C  A  G  G  A  C  T  T  T  A-
G  T  G  G  A T  T  C  C  T  G  A  A  A  C  T  G  G  A  G  G  T  C  T  C  C  A T  C  A  C  A  C  G  C  T  G  T  T A  C  T  T  G  A  A  C  A  G  G-
T  A  T  A  T  G  T  C  T  C  T  G  A  T  T  C  T  C  C  C  G  G  A  G  C  A  G  T  T  C  T  G  T  A  G  C  G  C  T  C  T  A  C  C  T  T  C  T  A  A-
T  C  T  T  C  T  G  T  G  C  C  G  G  C  T  -3′) and the APEX1 promoter as a positive E-box 
  control (APEX forward, 5′-T  A  C  C  A  C  G  A  A  C  A  A  C  C  C  A  G  A  A  C  C  -3′; APEX re-
verse, 5′-G  T  A  C  C  T  G  A  C  C  T  C  C  C  A  A  C  G  A  A  G  -3′). Real-time qPCR was used to 
quantify the fold enrichment relative to background detected with rabbit 
IgG for each primer set. The irrelevant gene 45S was ampliﬁ  ed to normal-
ize samples (45S forward, 5′-T  G  A  A  T  T  G  T  G  G  C  C  C  T  G  A  G  T  G  A  T  A  G  G  -3′; 45S 
reverse, 5′-G  A  G  T  G  G  T  G  T  T  T  G  T  G  T  G  T  G  T  G  T  T  G  G  -3′).
Genomic PCR and RT-PCR
For PCR analysis of c-and N-myc alleles, single-cell suspensions of total BM 
from control or mutant mice were stained with anti-B220 and anti-CD43 
antibodies, and cell sorting was performed on a FACSaria; alternatively, 
cells were magnetically labeled with CD19 microbeads and positively 
selected with an autoMACS Separator (Miltenyi Biotec). The FACS-sorted 
B220
+CD43
− and B220
+CD43
+ populations were directly lysed in PCR 
lysis buffer (Iritani et al., 1999). Puriﬁ  ed CD19
+ B lineage cells were cul-
tured with 10 ng/ml IL-7 for 0, 15, or 22 h before lysis with PCR lysis buf-
fer. The resulting DNA was used directly for PCR at 10,000 genomes/μl. 
Primers used to amplify the ﬂ   oxed undeleted and deleted c-and N-myc 
  alleles have been described previously (de Alboran et al., 2001; Knoepﬂ  er 
et al., 2002). Deletion of c-myc was quantiﬁ  ed by real-time PCR measure-
ments of the c-myc
ﬂ  /ﬂ   PCR product in the presence or absence of CD19cre. 
PCR analysis for D-J and V-D-J rearrangement of the Ig HC was performed 
as previously described (Iritani et al., 1999).
Real-time quantitative RT-PCR
RNA from puriﬁ  ed Wt and Eμ-c-myc splenic B cells, Wt and Eμ-c-myc 
  total BM, or FACS-sorted B220
+ Eμ-c-myc/RAG2
−/−, RAG2
−/−, and CD-
19cre c-myc
ﬂ / ﬂ  N-myc
ﬂ / ﬂ  B cell progenitors was extracted using the 
RNAqueous-4PCR kit (Ambion). cDNA was generated using Superscript II 
Reverse Transcriptase (Invitrogen). Samples were normalized using 
β-actin (β-actin forward [5′-T  C  C  T  T  C  G  T  T  G  C  C  G  G  T  C  C  A  C  -3′] and β-actin 
reverse [5′-A  C  C  A  G  C  G  C  A  G  C  G  A  T  A  T  C  G  T  C  -3′]) or eif1α (eif1α forward 
[5′-A  G  T  G  A  G  C  A  C  T  G  T  T  A  A  G  A  G  A  C  T  G  C  C  -3′] and eif1α reverse [5′-C  G  C-
A  G  C  C  A  G  A  T  G  A  C  T  A  G  A  G  T  A  C  A  A  -3′]). c-myc levels were determined using the 
following primers: c-myc forward (5′-A  C  C  A  A  C  A  G  G  A  A  C  T  A  T  G  A  C  C  T  C  -3′) 
and c-myc reverse (5′-A  A  G  G  C  A  G  T  A  G  C  G  A  C  C  G  C  A  A  C  -3′). The   following 
primers were used for murine PMCA4: mPMCA4 forward (5′-T  C  G  T  G  A  C  A-
G  C  C  T  T  C  A  A  T  G  A  C  T  G  G  A  -3′), mPMCA4 reverse (5′-A  G  G  T  C  A  C  C  G  T  A  T  T  T  G-
A  T  C  T  G  G  G  C  A  -3′), and human PMCA4 (hPMCA4 forward [5′-ATGACCC-
A  C  C  C  T  G  A  A  T  T  C  G  C  C  A  T  A  -3′] and hPMCA4 reverse [5′-T  G  G  T  T  G  C  A  A  T  C  C-
A  C  C  G  C  A  T  T  G  T  -3′]).
Primers specific for the various isoforms of murine NFATc1 and 
NFATc2 have been described previously (Asagiri et al., 2005): NFATc1A 
forward (5′-G  G  T  A  A  C  T  C  T  G  T  C  T  T  T  C  T  A  A  C  C  T  T  A  A  G  C  T  C  -3′), NFATc1A reverse 
(5′-G  T  G  A  T  G  A  C  C  C  C  A  G  C  A  T  G  C  A  C  C  A  G  T  C  A  C  A  G  -3′), NFATc1B forward 
(5′-C  C  C  A  T  C  C  G  C  C  A  G  G  C  T  A  C  A  G  C  C  G  C  A  G  T  A  A  -3′), NFATc1B reverse 
(5′-T  T  C  G  G  T  A  A  G  T  T  G  G  G  A  T  T  T  C  T  G  A  G  T  G  G  T  A  C  C  -3′), NFATc1C forward 
(5′-C  C  C  A  T  C  C  G  C  C  A  G  G  C  T  A  C  A  G  C  C  G  C  A  G  T  A  A  -3′), NFATc1C reverse 
(5′-T  G  A  G  T  G  G  T  A  C  C  A  G  A  T  G  T  G  G  G  T  C  C  A  G  T  T  T  A  T  -3′),  NFATc2 forward 
(5′-C  A  C  G  C  C  T  T  C  T  A  C  C  A  A  G  T  A  C  A  C  A  G  G  A  T  -3′), and NFATc2 reverse (5′-A  C  A-
G  T  C  G  A  T  G  G  T  G  G  C  T  C  T  C  A  T  G  T  T  -3′). Primers used to amplify hypoxanthine-
guanine phosphoribosyl transferase (hprt) were as follows: hprt forward 
(5′-G  T  T  G  G  A  T  A  C  A  G  G  C  C  A  G  A  C  T  T  T  G  T  T  G  -3′) and hprt reverse (5′-G  A  G  G-
G  T  A  G  G  C  T  G  G  C  C  T  A  T  A  G  G  C  T  -3′).
Primers used to amplify GL Igκ transcripts have been described pre-
viously (Hayashi et al., 2003). Quantitative deletion analysis of ﬂ  oxed 
c-myc alleles was performed using genomic DNA from FACS-sorted CD-
19cre
− or cre
+ c-myc
ﬂ  /ﬂ   N-myc
ﬂ  /ﬂ   pro– and pre–B cells and primers speciﬁ  c 
for the ﬂ  oxed c-myc allele (de Alboran et al., 2001) using 45S measure-
ments to normalize. Experiments were performed using a real-time PCR 
system sequence detector (model 7300; Applied Biosystems) and a PCR 
system (Mx4000; Stratagene).
KLH immunization
Mice were immunized with KLH protein (Calbiochem) emulsiﬁ  ed in com-
plete Freund’s adjuvant (CFA; 1:1 vol/vol mixture of 1 mg/ml of sterile 
protein solution–CFA) by subcutaneous injection at the base of the tail. Two 
injection sites were administered with 50 μl of the mixture. Mice were 
killed after 7 d. KLH-speciﬁ  c antibody production was measured with a 
KLH-coated ELISA system. For IgM, IgG1, and IgG2a measurements, serums 
were diluted 1:200, 1:135, and 1:135, respectively.
Statistical analysis
One-tailed t test was used for all analyses except the Kaplan-Meier ana-
lyses, in which we used Prism software (version 4; Graph Pad) to generate 
two-tailed p-values.
Image acquisition and manipulation
Developed ﬁ  lms were scanned using Photoshop (version 8.0; Adobe), and 
adjustments of contrast and brightness were performed with Photoshop 
software. Scanned images were imported into Canvas (version 9.0.2; 
ACD Systems of America) for ﬁ  gure preparation. In reference to Fig. 5, the nu-
clear α-lamin control Western blots shown in Fig. 5 (C and E) and the β-actin 
control Western blot shown in Fig. 5 F were obtained by probing a separate 
gel. For evaluation of c- and N-myc deletion by densitometry (Fig. S1), band 
intensities representing the ratio of deleted to ﬂ   oxed alleles (with back-
ground subtracted) are shown below each lane and were quantiﬁ  ed by 
densitometry on an imaging system (AlphaImager 3400; Alpha Innotech).
Online supplemental material
Fig. S1 shows the speciﬁ  c deletion of c- and N-myc in B lineage cells. Fig. S2 
shows that the Eμ-myc Tg stimulates proliferation but not apoptosis of 
RAG2
−/− B cell progenitors or Ig HC exclusion in Wt B cell progenitors. 
Fig. S3 shows that the elevated Ca
2+ ﬂ  ux of Eμ-myc B cell progenitors 
correlates with increased maturation and proliferation and increased NFAT 
activity. Fig. S4 shows that chelation of Ca
2+ impairs Ca
2+ ﬂ  ux, matura-
tion, and proliferation of Wt and Eμ-myc B cell progenitors in vitro, that 
Myc interacts with the mouse PMCA4 promoter in Eμ-myc B cells, and real-
time PCR analyses of NFATc message from puriﬁ   ed splenic B cells and 
PMCA4 message from c- and N-myc–deleted pro–B cells. Fig. S5 shows total 
levels of NFAT protein in whole cell lysates from Wt and Eμ-myc B cells and 
fractionation controls for the separation of cytoplasmic and nuclear frac-
tions depicted in Fig. 5 (C–F). Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200704173/DC1.
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